Proof-of-concept Study of New Imaging Diagnostic in Patients With Suspected Alzheimer's Disease (clinicaltrials.gov) - Jul 12, 2022 - P1 | N=18 | Recruiting | Sponsor: Alzeca Biosciences, Inc.
First-in-human • New P1 trial • Alzheimer's Disease • CNS Disorders
|